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ABSTRACT 
Nitrate (NO3-) and nitrite (NO2-) are known to be 
cardioprotective and to alter energy metabolism 
in vivo. NO3- action results from its conversion to 
NO2- by salivary bacteria, but the mechanism(s) 
by which NO2- affects metabolism remains 
obscure. NO2- may act by S-nitrosating protein 
thiols, thereby altering protein activity. But how 
this occurs, and the functional importance of S-
nitrosation sites across the mammalian proteome 
remains largely uncharacterized. Here we 
analyzed protein thiols within mouse hearts in 
vivo using quantitative proteomics to determine 
S-nitrosation site occupancy. We extended the 
thiol-redox proteomic-labelling technique, ICAT 
(Isotope-Coded Affinity Tag), to quantify the 
extent of NO2--dependent S-nitrosation of 
proteins thiols by in vivo. Using this approach, 
called SNOxICAT, we found that exposure to 
NO2- under normoxic conditions, or exposure to 
ischemia alone, results in minimal S-nitrosation 
of protein thiols. However, exposure to NO2- in 
conjunction with ischemia led to extensive S-
nitrosation of protein thiols across all cellular 
compartments. Several mitochondrial protein 
thiols exposed to the mitochondrial matrix were 
selectively S-nitrosated under these conditions, 
potentially contributing to the beneficial effects 
of NO2- on mitochondrial metabolism. The 
permeability of the mitochondrial inner 
membrane to HNO2, but not to NO2-, combined 
with the lack of S-nitrosation during anoxia alone, 
or by NO2- during normoxia place constraints on 
how S-nitrosation occurs in vivo and on its 
mechanisms of cardioprotection and modulation 
of energy metabolism. Quantifying S-nitrosated 
protein thiols now allows for determining 
modified cysteines across the proteome and for 
identifying those most likely responsible for the 
functional consequences of NO2- exposure.   
 
 
INTRODUCTION 
 Until recently nitrate (NO3-) and nitrite 
(NO2-) were considered biologically inert 
byproducts of NO metabolism in mammals, but 
now it is clear that they impact significantly on 
mammalian physiology and energy metabolism 
(1). Dietary NO3- is converted to NO2- by salivary 
bacteria (2), and this NO2- is thought to account 
for most of the biological properties of NO3- in 
mammals. For example, NO2- can act in vivo as a 
cytoprotectant during cardiac ischemia-
reperfusion injury (3-5), as well as acting as a 
modulator of mitochondrial function (4) and 
exercise efficiency (6). How NO2- has its effects 
in vivo is unclear, but a major component seems 
to be via the S-nitrosation (or S-nitrosylation) of 
cysteine residues on proteins (7) (Fig. 1A). 
Protein cysteine S-nitrosation is a post-
translational modification through which NO and 
its metabolites exert some of their actions by 
reversibly altering protein function (8-18). 
Therefore a plausible mode of action of NO2- in 
vivo is via protein-S-nitrosation (Fig. 1A). This 
notion is supported by a number of studies that 
have shown that NO2- treatment in vivo broadly 
increases protein S-nitrosation (3-5).  
 Even so, the functional relevance of S-
nitrosation by NO2- in vivo remains uncertain. 
This is in part because the proteomic methods 
used to identify the cysteine residues and proteins 
affected by S-nitrosation (18-20) do not measure 
the extent of cysteine modification. 
Quantification of the extent of protein S-
nitrosation on a particular cysteine residue (i.e. 
site occupancy) is essential to identify functional 
nodes through which S-nitrosation may have its 
physiological and pharmacological roles. While 
many cysteine residues may be modified 
indiscriminately to a low extent, these alterations 
are unlikely to have major physiological 
consequences; instead we expect that only those 
cysteine residues that are extensively modified by 
NO2- can explain the biological actions of this 
signaling modality (although we cannot exclude 
gain of function effects). To address this unmet 
need, we adapted cysteine-reactive isotope coded 
affinity tag (ICAT) approaches (21), which both 
identify and quantify the extent of reversible 
modification of a cysteine residue (22-25). To do 
this we modified the sample processing so that 
instead of identifying all reversibly modified 
protein thiols, only S-nitrosated cysteines are 
analyzed and quantified. Application of this 
approach, which we term SNOxICAT, allowed us 
to identify cysteine residues that are S-nitrosated, 
and most importantly quantify the extent of their 
S-nitrosation.  
 Here we have used SNOxICAT to study 
the impact of NO2- on the mouse heart in vivo. The 
heart was chosen because of the substantial 
interest in uncovering the mechanisms underlying 
both the cytoprotective and other metabolic 
modulatory effects of NO2- on cardiac function 
(1). Using this approach we have identified a 
range of protein thiols that were S-nitrosated by 
NO2- in the heart and quantified the extent of this 
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modification. Interestingly, the number of protein 
thiols in the heart substantially modified by NO2- 
was dramatically increased by ischemia, 
suggesting that the combination of NO2- and 
ischemia is necessary for extensive S-nitrosation 
in vivo. S-nitrosation was not increased by NO2- 
during normoxia, or by ischemia alone. 
Furthermore, several protein thiols S-nitrosated 
by NO2- during ischemia were on mitochondrial 
proteins providing a potential mechanistic link to 
the effects of NO2- on mitochondrial function.  
  
RESULTS AND DISCUSSION 
Using SNOxICAT to identify and quantify 
S-nitrosation of cardiac proteins in vivo - In 
exploring how NO2- might lead to protein S-
nitrosation, and to infer those proteins with 
potential physiological roles, we wanted to both 
identify the sites of S-nitrosation in vivo and also 
quantify the extent of modification on individual 
targets. However, S-nitrosothiols are too unstable 
to survive analysis, hence they need to be 
measured indirectly. To do this we extended the 
redox-proteomic method OxICAT, which uses 
Cys-ICAT chemistry to both quantify and 
identify thiols that are reversibly oxidized, which 
has been applied to Escherichia coli (22), 
Saccharomyces cerevisiae (25), Caenorhabditis 
elegans (23), Drosophila melanogaster (24) and 
to the mouse heart (26). OxICAT identifies 
reversibly oxidized protein thiols, so we refined 
OxICAT to develop the SNOxICAT approach, 
which reports on S-nitrosated protein thiols (Fig. 
1B). To do this tissue samples were rapidly 
stabilized by solubilization in trichloroacetic acid 
(TCA) in the presence of sulfanilamide (Fig. 1B), 
which both preserved endogenous S-nitrosothiols 
and prevented artifactual S-nitrosation of free 
thiols by acidified NO2- during sample work-up 
(27) (Fig. 1B). Following stabilization, the 
samples were neutralized and unmodified 
cysteine residues were labelled with "light" C0-
ICAT (Fig. 1B), then protein S-nitrosothiols were 
labeled with "heavy" C9-ICAT after their 
selective reduction by Cu(I) was achieved by 
adding low concentrations of ascorbic acid and 
CuSO4 (Fig. 1B) (28,29). Then the sample was 
digested with trypsin and cysteine-containing 
peptides that had reacted with C0-ICAT or C9-
ICAT were enriched by affinity purification using 
the biotin tag on the ICAT reagents, separated by 
liquid chromatography and analyzed by mass 
spectrometry (MS). As both the C0 and C9 ICAT 
labeled peptides are chemically identical and 
elute at the same point after liquid 
chromatography this enabled the extent of 
modification of the cysteine residue of interest to 
be quantified. In-line sequencing enabled the 
peptides, and their cognate proteins, to be 
identified by MS/MS. Hence, we could identify 
those protein cysteine residues that were S-
nitrosated in vivo and at the same time determine 
the extent of this modification.  
 Quantitative MS/MS data obtained from 
this approach were applied to several cardiac 
interventions in vivo (Fig. 1C). Data from 
individual experiments were cross-referenced 
using an HPLC-MS alignment algorithm to 
maximize peptide coverage (30). This enabled 
both the identification and the quantification of 
heavy and light ICAT signals for 2203 cysteine 
residues in the myocardium that came from 721 
proteins (Table S1). These signals were converted 
to a % S-nitrosation value ((100 x 
heavyICAT)/(heavyICAT+lightICAT)) for each 
particular cysteine residue (Table S2). From the 
total pool of identified cysteine peptides with 
quantitative S-nitrosation data, between 1,235-
1,868 were quantified at least 3 times. One 
complication with quantifying S-nitrosation is 
that many cysteines are not S-nitrosated at all, 
hence ~55% of residues have only one ICAT 
label. A failure to observe both labels can occur 
because the residue is either not S-nitrosated or is 
fully S-nitrosated, alternatively it may occur for 
technical reasons related to MS instrumentation 
and software. Thus, while it is biologically 
important to include these 0% and 100% S-
nitrosated values, a proportion of them are 
technical artifacts related to a failure in peak 
identification. To provide an accurate 
representation of in vivo S-nitrosation required 
differentiation between these two scenarios. To 
do this we noted that a hallmark of informative 
data points is that they should have similar S-
nitrosation across biological replicates and thus a 
low corresponding SEM. Conversely, apparent S-
nitrosation values arising due to technical 
artifacts are unconstrained by the S-nitrosation of 
their biological replicates and thus are likely to 
exhibit higher SEM values. Thus, a further 
curated dataset was generated where peptides 
with a highly variable cysteine S-nitrosation state 
were assumed to arise due to technical artifact and 
were excluded (see Figure S1 and the Materials 
and Methods for further discussion) leaving 866-
1,581 peptides (Table S3). The total number of 
cysteine containing peptides in an in silico trypsin 
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digest of the total mouse genome is ~320,000, 
hence we observe about ~0.5 % of the total 
number of cysteine residues present in the mouse 
genome. 
 We first used this approach to explore the 
baseline levels of S-nitrosation in the normoxic 
heart (Fig. 2A, Table S1). Under normoxic 
conditions we found 907 cysteine residues with 
some degree of sensitivity to Cu/ascorbate 
consistent with S-nitrosation. This is in agreement 
with previous studies that have established 
widespread S-nitrosation under baseline 
conditions in vivo (19). However, of all the 
cysteine residues identified, over half were less 
than 1% S-nitrosated (Fig. 2A) while only a small 
number (~5%, n=72) were greater than 50% S-
nitrosated. Thus, under basal conditions there is 
low-level S-nitrosation of several protein thiols, 
but very few cysteine residues are extensively 
modified, demonstrating the importance of 
quantifying site occupancy. 
 We were particularly interested in 
assessing the degree of protein S-nitrosation in 
mitochondria compared to the rest of the cell. 
Therefore we divided S-nitrosated proteins into 
mitochondrial or non-mitochondrial (Fig. 2B), 
and then further separated out those proteins that 
were S-nitrosated by greater than 50% (Fig. 2C). 
These analyses showed that there was a slight 
diminishment in enrichment of S-nitrosation in 
mitochondrial proteins under basal conditions.  
 Effect of NO2- on protein S-nitrosation in 
the normoxic and ischemic heart - To assess the 
effect of NO2- on protein thiols in the heart we 
injected NaNO2 intravenously into mice at a 
concentration that has been reported to protect the 
heart against ischemia-reperfusion (IR) injury 
and drive S-nitrosation in the heart (4,31) (Fig. 
1C). The S-nitrosation status of cysteine residues 
in the heart of normoxic mice was largely 
unchanged by NO2- injection (Fig. 3A). As the 
extent of S-nitrosation by NO2- has been shown to 
increase upon ischemia (4), we next set out to 
assess the effects of NO2- on cardiac S-nitrosation 
following exposure to 25 min ischemia (Fig. 3A). 
Under these conditions, administration of NO2- 
led to a dramatic increase in overall S-nitrosation 
in the ischemic myocardium, although ischemia 
alone did not increase S-nitrosation (Fig. 3A). 
These changes are quantified in Fig. 3B as the 
means of the extent of S-nitrosation of all the 
peptides. Together, these data in Figs. 3A, B 
suggested that there was an increase in the 
average extent of S-nitrosation when there was a 
combination of NO2- and ischemia, but not with 
either alone.   
 To test the effectiveness of the dataset 
curation and assess changes in S-nitrosation 
further, we switched our focus from aggregate 
levels of S-nitrosation under different conditions 
to the S-nitrosation of individual cysteine 
residues. As there was no apparent biological 
shift in S-nitrosation at the population level in 
response to NO2- alone relative to control, this 
provided an opportunity to test the validity of our 
previously described curation. As expected, the 
raw and curated plots of these two independently 
determined values coalesced around a line of 
slope ~1, with most values clustering near the 
origin (Figs. S1A and S1C). Furthermore, the 
shift in S-nitrosation with NO2- and ischemia is 
readily apparent in both the non-curated and 
curated datasets (Figs. S1B and S1D). The data 
points excluded from analysis show no such 
correlation and lacked an excess of statistically 
interesting comparisons above the false discovery 
rate (FDR; Figs. S1E and S1F). Together this 
argues that our curation is appropriate and 
effective. Next, we compared how the extent of 
S-nitrosation of individual peptides altered under 
different conditions. Volcano plots were created 
to assess changes in S-nitrosation on individual 
peptides in response to NO2- alone, ischemia 
alone, and ischemia + NO2-, all relative to control 
conditions. There was a clear bias towards 
peptides being significantly S-nitrosated by 
ischemia + NO2- (Fig. 4A). This was not observed 
in the symmetrical plots for NO2- (Fig. 4B) or 
ischemia alone (Fig. 4C). This is illustrated 
further in Fig. 4D, which examines the increase in 
S-nitrosation on individual peptides. Along the x-
axis we have plotted the increase in S-nitrosation 
on peptides when tissue exposed to NO2- and 
ischemia is compared to normoxic tissue exposed 
to NO2-. Then along the y-axis we have plotted the 
increase in S-nitrosation on peptides when tissue 
exposed to NO2- and ischemia is compared to 
ischemic tissue. The majority of peptides (82%) 
appear in the top right quadrant with a slope of 
~1, consistent with S-nitrosation being a process 
that depends on both ischemia and NO2-. Of the 
1081 cysteines present in both control tissue and 
that exposed to NO2- and ischemia, statistical 
comparisons could be made for 644 and of these 
264 were significantly changed (p < 0.05). This is 
an excess of 232 over the false discovery rate of 
32 (Fig. S1D). After Benjamini-Hochberg 
correction for multiple comparisons, 102 cysteine 
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residues could be identified as changing in 
response to NO2- and ischemia (Table S4). 
However, while there is a statistically significant 
shift in the S-nitrosation status of a large number 
of peptides with ischemia + NO2-, many cysteines 
are not S-nitrosated at all in the control heart and 
are consequently lost from statistical 
comparisons. Consequently we have focused on 
large absolute shifts in S-nitrosation as these are 
most likely to contribute to biologically 
meaningful changes to protein function within the 
tissue. Table S4 shows the 163 sites where NO2- 
in the ischemic myocardium increases S-
nitrosation by more than 10 percentage points 
above conditions of normoxia, NO2- alone, or 
ischemia alone.  
 Thus, we conclude that there is a 
substantial population of protein cysteines that 
become selectively S-nitrosated by NO2- in the 
ischemic heart but which are unmodified by NO2- 
under normoxic conditions, or by ischemia alone. 
This is in agreement with previous studies that 
show that overall levels of S-nitrosothiols 
increase following NO2- administration under 
ischemic conditions (32). 
 S-nitrosation of mitochondrial 
oxidoreductases by NO2- during ischemia - NO2- 
has a number of effects on mitochondrial 
metabolism and several of the most substantially 
modified targets of S-nitrosation were 
mitochondrial. To further examine the selective 
quantitative effects of S-nitrosation by NO2- in the 
ischemic heart, we clustered proteins with 
cysteine thiols exhibiting differential S-
nitrosation status (defined as >10 percentage 
points between conditions) using Gene Ontology 
(GO) term enrichment, with the total identified 
population of cysteine thiol containing proteins as 
the reference background. This approach 
identified S-nitrosation targets specific to each 
intervention that clustered in specific cellular 
pathways (Fig. 5A and Table S5). Among the 
most prevalent targets selectively modified by 
ischemic NO2- were mitochondrial 
oxidoreductases present in redox metabolism, 
electron transport, and the mitochondrial TCA 
cycle pathways (Fig. 5A and Table S5). 
Interestingly, despite this selective S-nitrosation 
of mitochondrial oxidoreductases, the average 
extent of S-nitrosation of all mitochondrial 
peptides (Fig. 5B) was similar to that observed for 
non-mitochondrial peptides (Fig. 5C). This 
suggests that mitochondrial oxidoreductases may 
be selective targets for modification even when 
compared to other mitochondrial proteins. 
Indeed, many of the pathways identified as 
enriched targets in the ischemic NO2- treatments 
are present in the mitochondrial matrix, as 
opposed to mitochondrial protein thiols that face 
the intermembrane space, or are located on the 
outer membrane. The mitochondrial matrix is a 
distinct compartment from the rest of the cell with 
an environment that may impact on NO2- 
metabolism during ischemia. To get a clearer 
picture of whether S-nitrosation was occurring in 
the mitochondrial matrix in response to 
exogenous NO2- we limited the analysis to soluble 
enzymes from the TCA cycle which are all 
present in the mitochondrial matrix (Table S3). 
When this was done there was again a clear 
increase in S-nitrosation within the mitochondrial 
matrix in response to NO2- and ischemia (Fig. 
5D). Thus, the combination of NO2- and ischemia 
leads to a clear increase in S-nitrosation within the 
mitochondrial matrix, although how this takes 
place is not clear.  
 To explore how the combination of NO2- 
and ischemia might impact on the mitochondrial 
matrix, we examined whether NO2- itself could 
gain access to the mitochondrial matrix. When 
mitochondria were incubated in a high 
concentration of KNO3 the organelles did not 
swell until the K+ ionophore valinomycin was 
added to enable K+ entry along with NO3-.  
Valinomycin allows for net uptake of KNO3 and 
thereby leads to swelling consistent with the 
mitochondrial inner membrane being permeable 
to NO3- (Fig. 5E). In contrast, when mitochondria 
were incubated in KNO2 addition of valinomycin 
did not lead to swelling (Fig. 5E), suggesting that 
the mitochondrial inner membrane is not 
permeable to NO2- per se. However, when NO2- 
uptake was examined in the presence of 
valinomycin, along with the uncoupler carbonyl 
cyanide p-trifluoromethoxyphenylhydrazone 
(FCCP) to render the inner membrane permeable 
to protons, this did lead to mitochondrial swelling 
(Fig. 5E). This indicates that in vivo NO2- itself is 
unlikely to enter mitochondria, but that its 
conjugate acid HNO2 (pKa = 3.16) can.  
Therefore, one possibility is that in vivo during 
ischemia NO2- leads to mitochondrial protein S-
nitrosation by generating membrane-permeant 
HNO2 that can diffuse into the matrix. This 
membrane permeability may be further enhanced 
by the acidic environment likely to be present in 
ischemic tissue and could contribute to the 
increase in S-nitrosation observed with NO2- and 
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ischemia relative to NO2-alone. However, the 
mechanism by which NO2- leads to S-nitrosation 
is unclear and may require the further reaction of 
HNO2 to potential S-nitrosating species such as 
N2O3, or  catalysis by metalloenzymes. 
To explore further how ischemic 
exposure to NO2- might affect mitochondrial 
oxidoreductase function, we examined the 
localization of substantially S-nitrosated sites on 
these mitochondrial pathways. We focused 
specifically on mitochondrial oxidoreductase 
sites that were identified as a cluster that is 
selectively modified by ischemic NO2- (Table 
S5). Within this cluster we found 22 sites that 
mapped to subunits of the OXPHOS machinery 
(Fig. 6A), and many in regions that have been 
implicated in regulating oxidative metabolism. 
For example, complex IV is S-nitrosated on 
cysteine residues 112 or 115 (Fig. 6B), which co-
ordinate Zn2+ binding and have been suggested to 
regulate aspects of complex function (33). 
Complex III is modified on cysteine residue 139 
of subunit IV (Fig. 6C), proximal to the 
cytochrome c reduction site, while both the 
electron transferring flavoprotein (ETF - Fig. 6D) 
and succinate dehydrogenase (SDH – Fig 6E) are 
modified at locations proximal to their flavin 
oxidation sites. The OXPHOS complex 
containing the most ischemic S-nitrosation sites 
(8), was complex I, most notably on four cysteine 
residues on the NDUFV1 subunit containing the 
flavin mononucleotide that is the proximal 
electron acceptor from NADH (Figs. 6F-H). In 
addition, there was substantial S-nitrosation on 
the ND3 subunit as cysteine 39, which is close to 
the ubiquinone binding site, while its S-
nitrosation is established to inhibit complex I in 
the ischemic myocardium (16). Substantial S-
nitrosation of cysteine residues on NDUFA10 and 
NDUFA11 was also observed (Figure 6G). 
NDUFA11 contributes the contact points 
between complex I and complex III (34,35) and 
the two cysteines may form two disulfides with a 
further two cysteines on NDUFA11 that were on 
peptides not observed by SNOxICAT.  
In addition to ischemic NO2- 
modifications that cluster to functional domains 
of OXPHOS complexes, it is noteworthy that 
under basal conditions substantial Cu/ascorbate 
sensitive modification was observed on a cysteine 
residues of two isoforms of the ADP/ATP carrier 
(AAC1&AAC2). Both exhibited substantial 
Cu/ascorbate sensitive modification of cysteine 
257 during normoxia (Fig. 6I), despite the two 
peptides containing cysteine 257 differing in 
sequence and consequently mass. Under basal 
conditions this site was among the most 
substantially modified site observed (60 – 100% 
S-nitrosated). The nature of this modification is 
unclear as it was largely unmodified under 
ischaemic conditions. This site may be of 
particular interest, as chemical modification of 
this cysteine residue has been shown to have 
substantial effects on AAC protein activity (36). 
Furthermore, chemical and redox modification of 
carrier proteins at this conserved cysteine site 
have been shown to affect carrier function and 
mitochondrial metabolism(37-39).  
  
CONCLUSIONS 
 The mechanism by which NO2- 
modulates cardiac function in vivo is not clear. To 
address this, we applied ICAT labelling methods 
(22,24), to both identify and quantify S-
nitrosation occupancy of protein cysteine 
residues across the proteome. Application of this 
approach, which we term SNOxICAT, allowed us 
to both identify and quantify the targets of S-
nitrosation by NO2- in the heart in vivo for the first 
time.  
Interestingly, only during ischemia were 
targets modified in the heart by NO2-. This 
suggests that the conditions during ischemia 
enhance protein S-nitrosation and that oxygen 
and/or pH are thus an important constraint on how 
NO2- interacts with metabolism. S-nitrosation was 
not confined to a particular cellular compartment 
and was distributed throughout the tissue. The 
NO2- anion itself is membrane impermeant and so 
does not enter mitochondria, suggesting that 
ischemic NO2- leads to mitochondrial S-
nitrosation due to the membrane permeation of its 
conjugate acid HNO2. Quantitative assessment of 
the mitochondrial targets of S-nitrosation 
revealed a number of interesting candidates for 
further studies to assess the functional 
consequences of these modifications and provide 
an important starting point to further assess how 
NO2- exerts its effects on mitochondrial function. 
In summary, we have developed a new technical 
approach that provides important new 
information on how NO2-  and NO3- may have 
their beneficial effects in vivo.  
 
EXPERIMENTAL PROCEDURES 
 Mouse experiments- For in vivo heart 
procedures, an open-chest, in situ heart model 
was used as previously described (40). Briefly, 
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male C57BL/6 mice (8–10 weeks; Charles River 
Laboratories) were anaesthetized with sodium 
pentobarbital (70 mg/kg intraperitoneally), 
intubated endotracheally and ventilated at 110 
breaths per minute with tidal volume between 125 
and 150 ml. A thoracotomy was performed and a 
prominent branch of the left anterior descending 
coronary artery was surrounded by a 7-0 Prolene 
suture that was passed through a small plastic 
tube. Ischemia was induced by tightening the 
tubing against the heart surface. Mice were 
divided into four groups: normoxia (sham-
operation in which the suture was placed but the 
left anterior descending coronary artery was not 
occluded); normoxia + 10 mg/kg systemic 
intravenous sodium nitrite; 30 min ischemia; and 
30 min ischemia + 10 mg/kg systemic 
intravenous sodium nitrite administered at 25 min 
ischemia (31). 
 Cys-ICAT labelling of heart tissue - At all 
times during S-nitrosothiol derivitization, 
samples were shielded from light. Following in 
vivo interventions, heart tissue was rapidly 
excised and immediately homogenized in ice cold 
20% TCA containing 0.5% sulfanilamide. The 
homogenate was incubated on ice for 30 min and 
then pelleted for 30 min at 16,000 x g at 4°C. The 
pellet was washed with 10% and 5% (w/v) TCA 
and then resuspended in 80 μl denaturing 
alkylating buffer (DAB; 6 M urea, 2% (w/v) SDS, 
200 mM Tris-HCl, 10 mM EDTA, 100 μM 
DTPA, 10 μM neocuproine). The contents of one 
vial of cysteine reactive cleavable ICAT reagent 
(AB SCIEX) was added to each biological 
replicate sample to label reduced cysteine 
residues at 37°C and mixed at 1,400 rpm for 2 h 
on an Eppendorf Thermomixer. Sample protein 
was precipitated with 20% TCA, incubated at 4°C 
for 30 min, and pelleted at 4 °C and 16,000 x g 
for 30 min. The pellet was washed twice as above 
and then re-solubilized in 100 μl DAB containing 
10 μM CuSO4 and 1 mM ascorbic acid to reduce 
protein S-nitrosothiols, in the presence of a 
second isotopically heavy cysteine reactive 
cleavable ICAT reagent. Proteins were incubated 
at 37°C and mixed at 1,400 rpm for 2 h. The 
amount of protein to be processed was optimized 
to ensure saturation of thiol labelling by the ICAT 
reagent as per the manufacturer’s instructions. 
The sample was precipitated with 5 vol. ice-cold 
acetone, stored at -20 ̊C for 2 h and pelleted at 
4̊C at 16000 x g for 30 min. The pellet was 
washed twice with 90% ice-cold acetone and then 
resuspended in denaturing buffer and 1 vol. 
trypsin (AB SCIEX, resuspended in H2O) was 
added (both provided by the ICAT kit). Proteins 
were digested at 37˚C with mixing at 1400 rpm 
overnight. Digested peptides were enriched for 
cysteine-containing peptides first on a cation 
exchange cartridge and then subsequently on an 
avidin affinity cartridge (AB SCIEX) as 
described previously (24). Eluted cysteine-
containing, ICAT labeled peptides were dried 
down overnight in a Speed Vac and the biotin 
moiety of the ICAT label was removed by 
incubation with the cleaving reagents provided in 
the ICAT kit for 2 h at 37 ̊C with mixing at 1400 
rpm). The isolated peptides were then dried down 
in a Speed Vac for MS analysis. 
 LC-MS/MS analysis of peptides and data 
analysis - The LC-MS/MS analysis of the 
SNOxICAT labelled peptides was carried out 
using an Orbitrap LTQ XL (Thermo Scientific) 
where peptides were analyzed after 
chromatography on a nanoscale reverse-phase 
column (75 µm inner diameter, 100 mm length) 
with a gradient of 0-40% buffer B (95% 
acetonitrile, 0.1% formic acid) in buffer A (5% 
acetonitrile, 0.1% formic acid) over 84 min at 300 
nL/min. Four biological replicates were 
processed for each experiment. Peptides were 
identified using Proteome Discoverer (Thermo 
Scientific) and the Mascot protein identification 
program (Matrix Science). All experiments used 
the Mouse UniProt database (2013_12). Searches 
were performed using a 5 ppm precursor ion 
tolerance, while requiring each peptide’s 
amino/carboxy (N/C) terminus to have trypsin 
protease specificity and allowing up to two 
missed cleavages. ICAT tags on cysteine residues 
(+227.13 & +236.16 Da) and methionine 
oxidation (+15.99492 Da) were set as variable 
modifications. Since many peptides were not 
observed in all replicates the raw files were then 
analyzed using MassChroQ software that 
quantifies peaks lacking MS2 sequence 
information by aligning them using the retention 
time of peptides common to runs for which MS2 
information was obtained(30). An in silico tryptic 
digest of the complete mouse proteome was 
performed using a modified proteogest script 
generating a file that listed all cysteine-containing 
tryptic peptides, with none, one or two missed 
cleavages, the cysteine residue number and the 
Uniprot accession number of the protein (41). The 
proteogest script modification was done by Dr 
Alan Robinson, MRC Mitochondrial Biology 
Unit. The peptide list generated by proteogest was 
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used together with the output from MassChroQ to 
sum intensity from all peptide peak signals 
containing the cysteine residue of interest (i.e. 
miss-cleaved, methionine oxidation, different z 
values) and give a combined signal for both heavy 
and light forms of the peptide. A significant 
complication with quantifying S-nitrosation 
compared to general oxidation is many cysteines 
are not S-nitrosated at all and consequently in this 
study under control conditions ~55% of residues 
in a particular replicate have only one ICAT label. 
A failure to observe both labels can also occur for 
technical reasons related to MS instrumentation 
and software, or it can arise because the residue is 
either not S-nitrosated at all or it is completely S-
nitrosated. The simplest mechanism for resolving 
this is to discard all peptides that lack both peaks, 
but excluding 55% of the dataset would give a 
misleading picture of in vivo S-nitrosation. 
Conversely, treating a failure of the 
instrumentation and software to find the correct 
peak as a biological result is also misleading. 
To differentiate between these two 
situations and provide a more accurate 
representation of in vivo S-nitrosation we utilized 
the expected similarity of informative data points 
across the four biological replicates. All data 
points with an SEM of less than 6 were 
considered informative and automatically 
included in the subsequent analyses, comprising 
78% of the total. For data points with an SEM > 
6, heavy and light ICAT signals were separately 
cross-referenced to the median heavy or light 
intensity of that cysteine in the 4 biological 
replicates. Those with an intensity signal < 20% 
of the heavy or light median intensity were 
excluded. This step prevents a single technical 
failure with either heavy or light peak in one 
replicate causing a group of four replicates to be 
eliminated from analysis. This was necessary as 
only 387 cysteine residues (~20%) were 
sufficiently S-nitrosated to be observed with both 
heavy and light isotope labels. Finally, all data 
points that still had an SEM > 8 or n < 3 were 
excluded. S-nitrosation is presented as the 
percentage: (100 x HeavyICAT)/(HeavyICAT + 
LightICAT). 
 Information on the subcellular 
localization of the proteins identified and the 
biological processes they participated in was 
obtained using MitoMiner (http://mitominer.mrc-
mbu.cam.ac.uk/). For bar charts, the data for 
distribution of proportion of cysteine residues 
against percentage S-nitrosation were generated 
by counting the number of cysteine residues in 
each 2% quantile for each individual biological 
replicate and then averaging the relative values 
for each quantile over the four biological 
replicates. For volcano plots of the extent of S-
nitrosation of a given cysteine under one 
condition against its S-nitrosation under another 
condition, the significance of the shift in S-
nitrosation was assessed by an f-test for variance 
followed by the appropriate two-tailed Student’s 
t test, assuming equal or unequal variance as 
appropriate. A Benjamini-Hochberg procedure 
was used to correct for multiple comparisons and 
thus determine significant changes 
 Mitochondrial experiments - Liver 
mitochondria were prepared from female Wistar 
rats killed by stunning and cervical dislocation, 
followed by homogenization of the liver and 
differential centrifugation in ice-cold STE buffer 
(250 mM sucrose, 10 mM Tris, 1mM EGTA, pH 
7.4). The protein concentration was determined 
by the biuret assay using bovine serum albumin 
as a standard. For swelling experiments 
mitochondria (0.5 mg protein/ml) were incubated 
in 10 mM TrisHCl, pH 7.2 at 37°C supplemented 
with rotenone (4 µg/ml) and containing either 
KNO2 or KNO3 (100 mM). Absorbance was 
measured at 550 nm and valinomycin (1 µM) or 
FCCP (2 µM) was added where indicated. The 
figure shows a typical result of 3 replicates. 
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FIGURE LEGENDS 
FIGURE. 1.  The SNOxICAT methodology. (A) S-nitrosation of sensitive surface protein thiols. A 
small subset of mitochondrial surface protein thiols are sensitive to S-nitrosation, which is thought to 
occur by two mechanisms. The thiolate form of a sensitive thiol can react with a nitrosonium ion to 
form an S-nitrosothiol (left). Alternatively, the thiyl radical form, generated by one elctron oxidation of 
a thiol or thiolate, may react directly with NO• to form an S-nitrosothiol (right). The resulting reversible 
modification may have functional consequences for the target protein, or alternatively could block other 
irreversible oxidative modifications from occurring on the thiol. (B) SNOxICAT methodology. 
Following in vivo interventions mouse myocardial tissue is excised and thiols stabilized by 
homogenization in 20% TCA containing 0.5% sulfanilamide. Unmodified protein thiols are labeled 
with C0-ICAT, following which S-nitrosated thiols are chemically reduced and labeled with C9-ICAT 
allowing for identification and quantification of the S-nitrosation status of protein thiols across the 
proteome. The peptides are then isolated and analyzed by mass spectrometry. (C) Experimental design 
for comparative analysis of S-nitrosation status in the mouse heart. 
 
FIGURE. 2.  Quantification of basal S-nitrosation in the mouse heart by SNOxICAT. (A) Overall 
detailed distribution of % S-nitrosation status of protein thiols in the heart under baseline conditions. 
The percentage S-nitrosation status is distributed in 2% quantiles indicating the proportion of total 
cysteines identified exhibiting a particular level of S-nitrosation. The inset shows an expansion of these 
findings. (B, C) Pie charts showing the relative amount of mitochondrial and non-mitochondrial S-
nitrosated cysteine residues in the myocardium under basal conditions for all S-nitrosated proteins 
detected (B), and for those proteins that were S-nitrosated by more than 50 % (C).  
 
FIGURE. 3.  Effect of NO2- on the S-nitrosothiol proteome in the mouse heart under normoxic and 
ischemic conditions. (A) Distribution of % S-nitrosation status of protein thiols in the heart under 
normoxia, normoxia + NO2-, ischemia and ischemia + NO2-. The percentage S-nitrosation status is 
distributed in 2% quantiles indicating the proportion of total cysteines identified exhibiting a particular 
level of S-nitrosation. The inset shows an expansion of these findings. (B) The mean % S-nitrosation of 
protein thiols under the four conditions are shown. Data are means ± SEMs. The numbers of peptides 
analyzed are indicated within each bar. 
 
FIGURE. 4.  Relative effect of NO2- on the S-nitrosation of individual peptides in the mouse heart 
under normoxic and ischemic conditions. (A-C) Volcano plots of the p value for the change in S-
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nitrosation for individual peptides, comparing the indicated conditions against normoxic control (D% 
points = % S-nitrosation under condition - % S-nitrosation under normoxia). The n values show the 
number of peptides for which there was sufficient data under the indicated condition and normoxia. (A) 
NO2- and ischemia, (B) NO2- alone, (C) ischemia alone. (D) Comparison of the shift in in S-nitrosation 
for a given peptide upon going from ischemia alone to ischamia + NO2-, shown on the y-axis, plotted 
against the shift in S-nitrosation for a given peptide upon going from NO2- alone to ischemia + NO2-. 
 
FIGURE. 5.  Intracellular localization of S-nitrosated protein thiols upon NO2- and ischemia. (A) 
Pathway analysis of proteins containing cysteine residues sensitive to selective S-nitrosation (>10 
percentage point average shift in S-nitrosation) in each treatment protocol indicating number of 
significantly enriched pathways(B, C) Sub-cellular localization of cysteines selectively targeted for S-
nitrosation by NO2- under ischemic conditions. (D) TCA cycle targets of S-nitrosation. (E) NO2- uptake 
assessed by swelling of mitochondria. Mitochondria (0.5 mg protein/ml) were incubated in 10 mM 
TrisHCl, pH 7.2 at 37 ˚C supplemented with rotenone (4 µg/ml) and containing either KNO2 or KNO3 
(100 mM). Absorbance was measured at 550 nm and valinomycin (1 µM) or FCCP (2 µM) was added 
where indicated. The figure shows a typical result of 3 replicates. 
  
FIGURE. 6. Identification of mitochondrial protein cysteine and pathway targets of S-nitrosation 
caused by ischemic NO2-. (A) Structures of OXPHOS enzymes with subunits containing targets of 
ischemic S-nitrosation by NO2- highlighted in red, with the number of S-nitrosated cysteine residues 
given in parentheses. (B-E) Quantification of S-nitrosation status of cysteine residues that are 
selectively modified by NO2- during ischemia on: (B) complex IV, (C) complex III, (D) electron transfer 
flavoprotein (ETF). and (E) succinate dehydrogenase (SDH).  Structures are also provided for target 
subunits containing flavin cofactors indicating the location of the flavin (yellow) and relevant cysteine 
residues. (F) Structure of mitochondrial complex I indicating subunits containing cysteine residues that 
are selectively modified by NO2- during ischemia highlighted in red, with the number of S-nitrosated 
cysteine residues given in parentheses. (G) Quantification of S-nitrosation status of complex I cysteine 
residues sensitive to modification by ischemic NO2-. (H)    Structures of the flavin-containing NDUFV1 
subunit indicating the location of the flavin (yellow) and relevant cysteine residues.  (G) Modification 
of S-nitrosation status of cysteine residue 257 on the ATP/ADP carriers (AAC) 1 and 2 under different 
conditions. 
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